Clinical Trial Update: Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic drug interaction study assessing potential interactions between dapagliflozin and glimepiride or sitagliptin in healthy subjects has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Glimepiride (glimepiride)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED